AC
GSK icon

Arjuna Capital’s GSK GSK Stock Holding History

Arjuna Capital’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.1M Buy
135,511
+12,309
+10% +$651K 1.6% 13
2026
Q1 		$6.8M Buy
123,202
+4,496
+4% +$244K 1.73% 10
2025
Q4 		$5.82M Sell
118,706
-37
-0% -$1.73K 1.43% 11
2025
Q3 		$5.12M Buy
118,743
+1,582
+1% +$61.8K 1.27% 14
2025
Q2 		$4.5M Sell
117,161
-6,169
-5% -$236K 1.19% 19
2025
Q1 		$4.78M Sell
123,330
-41,736
-25% -$1.53M 1.32% 17
2024
Q4 		$5.58M Buy
165,066
+86,132
+109% +$3.1M 1.49% 17
2024
Q3 		$3.23M Buy
78,934
+46,621
+144% +$1.91M 0.84% 42
2024
Q2 		$1.24M Buy
32,313
+235
+0.7% +$9.88K 0.33% 71
2024
Q1 		$1.38M Buy
32,078
+825
+3% +$34K 0.39% 69
2023
Q4 		$1.16M Buy
+31,253
New +$1.12M 0.36% 72
2022
Q3 		– Sell
-26,069
Closed -$1.42M – 96
2022
Q2 		$1.42M Buy
26,069
+700
+3% +$38.6K 0.69% 39
2022
Q1 		$1.38M Buy
25,369
+5,559
+28% +$302K 0.58% 48
2021
Q4 		$1.09M Buy
+19,810
New +$1.03M 0.4% 62
2020
Q3 		– Sell
-14,695
Closed -$749K – 92
2020
Q2 		$749K Buy
14,695
+185
+1% +$9.49K 0.52% 54
2020
Q1 		$687K Buy
+14,510
New +$774K 0.57% 50
2019
Q2 		– Sell
-3,950
Closed -$206K – 98
2019
Q1 		$206K Sell
3,950
-22,155
-85% -$1.11M 0.16% 90
2018
Q4 		$1.25M Sell
26,105
-247
-0.9% -$12.2K 1.14% 32
2018
Q3 		$1.32M Buy
26,352
+338
+1% +$17.2K 1% 37
2018
Q2 		$1.31M Sell
26,014
-5
-0% -$252 1.07% 38
2018
Q1 		$1.27M Buy
26,019
+1,085
+4% +$50.5K 1.07% 38
2017
Q4 		$1.1M Buy
+24,934
New +$1.15M 1.03% 36

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Arjuna Capital's GSK Position: Q2 2026 in Review

Arjuna Capital increased its GSK (GSK) stake by 10% in Q2 2026, buying an estimated $651K and bringing the position to 135,511 shares worth $7.1M. The position accounts for 1.6% of the portfolio, ranked #13.

Arjuna Capital first reported a position in GSK in Q4 2017 and has held it in 22 quarters since. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Arjuna Capital held 135,511 shares of GSK worth $7.1M as of Q2 2026.
  • Arjuna Capital bought 12,309 GSK shares in Q2 2026, an estimated $651K.
  • GSK made up 1.6% of Arjuna Capital's portfolio in Q2 2026, its #13 holding.
  • Arjuna Capital first reported a position in GSK in Q4 2017 and has held it in 22 quarters since.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Arjuna Capital's 13F filing for Q2 2026, filed 14 Aug 2026.